InvestorsHub Logo
Followers 8
Posts 867
Boards Moderated 0
Alias Born 01/19/2016

Re: None

Friday, 04/23/2021 9:27:32 PM

Friday, April 23, 2021 9:27:32 PM

Post# of 232739
If CD-12 or CD-10 meets their primary end point, FDA would have approve Pro-140 long ago. But reality is neither of the trials meets its end point, or statistically insignificant. It’s that simple, stop blame FDA or someone else. Nader or the company is the one at fault, either the drug is no better than placebo or Nader set the wrong end points. It’s that simple.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News